Literature DB >> 30557515

Lectin Complement Pathway in Emphysema.

Karina A Serban1,2, Andrew Mikosz1, Charlie Strange3, Sabina M Janciauskiene4,5, Jan Stolk6, Danny Jonigk4,5, Robert A Sandhaus1, Irina Petrache1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30557515      PMCID： PMC6396862          DOI： 10.1164/rccm.201807-1380LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   30.528


× No keyword cloud information.
  13 in total

1.  Oxidation of Z α1-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema.

Authors:  Sam Alam; Zhenjun Li; Sabina Janciauskiene; Ravi Mahadeva
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-22       Impact factor: 6.914

2.  Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.

Authors:  Anja Roos; Maria Pia Rastaldi; Novella Calvaresi; Beatrijs D Oortwijn; Nicole Schlagwein; Danielle J van Gijlswijk-Janssen; Gregory L Stahl; Misao Matsushita; Teizo Fujita; Cees van Kooten; Mohamed R Daha
Journal:  J Am Soc Nephrol       Date:  2006-05-10       Impact factor: 10.121

3.  Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement.

Authors:  R R Kew; B Ghebrehiwet; A Janoff
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

Review 4.  A review of α1-antitrypsin deficiency.

Authors:  James K Stoller; Loutfi S Aboussouan
Journal:  Am J Respir Crit Care Med       Date:  2011-09-29       Impact factor: 21.405

5.  alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis.

Authors:  Irina Petrache; Iwona Fijalkowska; Terry R Medler; Jarrett Skirball; Pedro Cruz; Lijie Zhen; Horia I Petrache; Terence R Flotte; Rubin M Tuder
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

6.  Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

Authors:  Kevin Molloy; Craig P Hersh; Valerie B Morris; Tomás P Carroll; Catherine A O'Connor; Jessica A Lasky-Su; Catherine M Greene; Shane J O'Neill; Edwin K Silverman; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

7.  Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.

Authors:  F Ogushi; G A Fells; R C Hubbard; S D Straus; R G Crystal
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

8.  Alpha-1 Antitrypsin and Lung Cell Apoptosis.

Authors:  Karina A Serban; Irina Petrache
Journal:  Ann Am Thorac Soc       Date:  2016-04

9.  Alpha 1-antitrypsin deficiency, complement activation, and chronic liver disease.

Authors:  E T Littleton; L Bevis; L J Hansen; M Peakman; A P Mowat; G Mieli-Vergani; D Vergani
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

Review 10.  Complement System Part II: Role in Immunity.

Authors:  Nicolas S Merle; Remi Noe; Lise Halbwachs-Mecarelli; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Front Immunol       Date:  2015-05-26       Impact factor: 7.561
View more
  1 in total

1.  MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19.

Authors:  Valéria Bumiller-Bini; Camila de Freitas Oliveira-Toré; Tamyres Mingorance Carvalho; Gabriela Canalli Kretzschmar; Letícia Boslooper Gonçalves; Nina de Moura Alencar; Miguel Angelo Gasparetto Filho; Marcia Holsbach Beltrame; Angelica Beate Winter Boldt
Journal:  Genet Mol Biol       Date:  2021-03-17       Impact factor: 1.771
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.